To assess clinical relevance, we explored an independent NSCLC cohort through the AMC OncoGenomics portal (GSE43580), where KRAS and TIMP1 mRNA levels showed an inverse association (Figure 1C) [28]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.